计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab175533-100μg |
100μg |
现货 ![]() |
| |
| Ab175533-1mg |
1mg |
现货 ![]() |
| |
| Ab175533-5mg |
5mg |
现货 ![]() |
| |
| Ab175533-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Etaracizumab (anti-Integrin aVb3), 整合素 αVβ3 抗体 |
|---|---|
| 别名 | Anti-αvβ3 Integrin Recombinant Antibody | 埃达组单抗 | 伊瑞西珠 | 整合素αV(ITGaV) | 整合素β3(ITGb3) | 依他赛珠单抗(抗整合素 aVb3) |
| 英文别名 | antigen identified by monoclonal antibody L230 antibody | CD 51 antibody | CD51 antibody | DKFZp686A08142 antibody | Integrin alpha five antibody | integrin alpha V beta 3 antibody | Integrin alpha-5 antibody | integrin alpha-V antibody | Integrin alpha-V |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | Integrin aVb3 (ITGAV & ITGB3) |
| 种属反应性 | 人(Human) |
| 偶联 | Unconjugated |
| 作用类型 | 拮抗剂 |
| 作用机制 | 整合素 αVβ3 抗体 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 26.2 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 185.3 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 892553-42-3 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Etaracizumab (anti-Integrin aVb3) (Ab175533) - Flow Cytometry
Flow Cytometry analysis of HUVEC cells labelling Integrin aVb3 (red) with Etaracizumab (anti-Integrin aVb3) (Ab175533). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Etaracizumab (anti-Integrin aVb3) (Ab175533) - SEC
The purity of Etaracizumab (anti-Integrin aVb3) (Ab175533) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab175533 | |
| 分析证书 | Ab175533 | |
| 分析证书 | Ab175533 |
| 1. Mulgrew K, Kinneer K, Yao XT, Ward BK, Damschroder MM, Walsh B, Mao SY, Gao C, Kiener PA, Coats S et al.. (2006) Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin.. Mol Cancer Ther, 5 (12): (3122-9). [PMID:17172415] |
| 2. Delbaldo C, Raymond E, Vera K, Hammershaimb L, Kaucic K, Lozahic S, Marty M, Faivre S. (2008) Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors.. Invest New Drugs, 26 (1): (35-43). [PMID:17876527] |
| 3. Felding-Habermann B, Cheresh DA. (1993) Vitronectin and its receptors.. Curr Opin Cell Biol, 5 (5): (864-8). [PMID:7694604] |